These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24032487)

  • 21. A crossover comparison of glycemic variations in Japanese patients with type 1 diabetes receiving insulin glargine versus insulin detemir twice daily using continuous glucose monitoring (CGM): J COLLECTION (Jikei COmparison of Lantus and LEvemir with Cgm for Thinking Insulin OptimizatioN).
    Tsujino D; Nishimura R; Morimoto A; Tajima N; Utsunomiya K
    Diabetes Technol Ther; 2012 Jul; 14(7):596-601. PubMed ID: 22775404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simulation-Based Evaluation of Dose-Titration Algorithms for Rapid-Acting Insulin in Subjects with Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antihyperglycemic Medications.
    Ma X; Chien JY; Johnson J; Malone J; Sinha V
    Diabetes Technol Ther; 2017 Aug; 19(8):483-490. PubMed ID: 28700249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Accuracy of Six Blood Glucose Monitoring Systems and Modeling of Possibly Related Insulin Dosing Errors.
    Baumstark A; Jendrike N; Pleus S; Haug C; Freckmann G
    Diabetes Technol Ther; 2017 Oct; 19(10):580-588. PubMed ID: 28704063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Once-daily insulin detemir is comparable to once-daily insulin glargine in providing glycaemic control over 24 h in patients with type 2 diabetes: a double-blind, randomized, crossover study.
    King AB
    Diabetes Obes Metab; 2009 Jan; 11(1):69-71. PubMed ID: 19120433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computerization of the Yale insulin infusion protocol and potential insights into causes of hypoglycemia with intravenous insulin.
    Marvin MR; Inzucchi SE; Besterman BJ
    Diabetes Technol Ther; 2013 Mar; 15(3):246-52. PubMed ID: 23289409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of miglitol as an add-on to bolus insulin on postprandial glycemic excursions in type 2 diabetes patients assessed by continuous glucose monitoring.
    Matsuura K; Mori Y; Nakamura A; Yokoyama J; Utsunomiya K
    Diabetes Technol Ther; 2012 May; 14(5):423-9. PubMed ID: 22316114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Classification of Postprandial Glycemic Status with Application to Insulin Dosing in Type 1 Diabetes-An In Silico Proof-of-Concept.
    Cappon G; Facchinetti A; Sparacino G; Georgiou P; Herrero P
    Sensors (Basel); 2019 Jul; 19(14):. PubMed ID: 31323886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship of glycemic control, insulin dose, and race with hypoglycemia in youth with type 1 diabetes.
    Chalew S; Kamps J; Jurgen B; Gomez R; Hempe J
    J Diabetes Complications; 2020 Jun; 34(6):107519. PubMed ID: 32303406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing sensor accuracy for non-adjunct use of continuous glucose monitoring.
    Kovatchev BP; Patek SD; Ortiz EA; Breton MD
    Diabetes Technol Ther; 2015 Mar; 17(3):177-86. PubMed ID: 25436913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of sensor-augmented pump therapy on glycemic variability in well-controlled type 1 diabetes in the STAR 3 study.
    Buse JB; Kudva YC; Battelino T; Davis SN; Shin J; Welsh JB
    Diabetes Technol Ther; 2012 Jul; 14(7):644-7. PubMed ID: 22524549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Silico Examination of Initiation of Long-Acting Insulin Analogs Toujeo Compared to Lantus Under 3 Dosing Titration Rules in Virtual Type 2 Diabetes Subjects.
    Sieber J; Weinheimer M; Kongable G; Riddle S; Chang YY; Flacke F
    J Diabetes Sci Technol; 2020 Sep; 14(5):898-907. PubMed ID: 31288531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accuracy of Capillary and Arterial Whole Blood Glucose Measurements Using a Glucose Meter in Patients under General Anesthesia in the Operating Room.
    Karon BS; Donato LJ; Larsen CM; Siebenaler LK; Wells AE; Wood-Wentz CM; Shirk-Marienau ME; Curry TB
    Anesthesiology; 2017 Sep; 127(3):466-474. PubMed ID: 28557817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between sensor-augmented insulin therapy with continuous subcutaneous insulin infusion or multiple daily injections in everyday life: 3-day analysis of glucose patterns and sensor accuracy in children.
    Zucchini S; Scipione M; Balsamo C; Maltoni G; Rollo A; Molinari E; Mangoni L; Cicognani A
    Diabetes Technol Ther; 2011 Dec; 13(12):1187-93. PubMed ID: 21854193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Islet Transplantation Provides Superior Glycemic Control With Less Hypoglycemia Compared With Continuous Subcutaneous Insulin Infusion or Multiple Daily Insulin Injections.
    Holmes-Walker DJ; Gunton JE; Hawthorne W; Payk M; Anderson P; Donath S; Loudovaris T; Ward GM; Kay TW; OʼConnell PJ
    Transplantation; 2017 Jun; 101(6):1268-1275. PubMed ID: 27490410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective Study of Postoperative Glycemic Control with a Standardized Insulin Infusion Protocol after Infrainguinal Bypass and Open Abdominal Aortic Aneurysm Repair.
    Steely AM; Smith L; Callas PW; Nathan MH; Lahiri JE; Stanley AC; Steinthorsson G; Bertges DJ
    Ann Vasc Surg; 2017 Oct; 44():211-220. PubMed ID: 28502888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis.
    Gaebler JA; Soto-Campos G; Alperin P; Cohen M; Blickensderfer A; Wintle M; Maggs D; Hoogwerf B; Han J; Pencek R; Peskin B
    Vasc Health Risk Manag; 2012; 8():255-64. PubMed ID: 22566747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Medical intensive care unit patients with hyperglycemia: is it possible a hypoglycemic risk close to zero?].
    Cosmi F; Mariottoni B; Cosmi D
    G Ital Cardiol (Rome); 2018; 19(7):460-466. PubMed ID: 29989603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved glycemic control in intensively treated adult subjects with type 1 diabetes using insulin guidance software.
    Garg SK; Bookout TR; McFann KK; Kelly WC; Beatson C; Ellis SL; Gutin RS; Gottlieb PA
    Diabetes Technol Ther; 2008 Oct; 10(5):369-75. PubMed ID: 18715213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites.
    Zisser H; Renard E; Kovatchev B; Cobelli C; Avogaro A; Nimri R; Magni L; Buckingham BA; Chase HP; Doyle FJ; Lum J; Calhoun P; Kollman C; Dassau E; Farret A; Place J; Breton M; Anderson SM; Dalla Man C; Del Favero S; Bruttomesso D; Filippi A; Scotton R; Phillip M; Atlas E; Muller I; Miller S; Toffanin C; Raimondo DM; De Nicolao G; Beck RW;
    Diabetes Technol Ther; 2014 Oct; 16(10):613-22. PubMed ID: 25003311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction in glycated albumin can predict change in HbA1c: comparison of oral hypoglycaemic agent and insulin treatments.
    Won HK; Kim KJ; Lee BW; Kang ES; Cha BS; Lee HC
    Diabet Med; 2012 Jan; 29(1):74-9. PubMed ID: 21781151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.